BACKGROUNDER CA-MRSA / STAPH INFECTIONS
CA-MRSA (Staph)
CA-MRSA or Community-Associated methicillin resistant Staphylococcus aureus (CAMRSA) more commonly known by athletes as Staph, is a type of skin infection caused by Staph bacteria. What makes this infection particularly serious is its resistance to many antibiotics. MRSA/Staph is often misdiagnosed as spider bites, notes Nora Boyd, chair of the CCAR-CAC Working Group and Infection Control Specialist with Bluewater Health in Ontario. The infection usually starts out as a small bump that looks like a pimple or a boil but becomes larger, redder and often develops pus drainage. MRSA/Staph infected skin lesions can progress quickly from a skin irritation to an abscess or serious skin infection. If left untreated, it can infect blood and bones and become life-threatening. FOR MORE INFORMATION CLICK HERE
Terms of Reference (September 15, 2004)
Mandate:
To provide the CCAR Executive with advice on appropriate activities related to infection prevention and control to limit the development and transmission of antibiotic resistance.
The Working Group will:
Priorities:
The key short term priorities will be:
a. to establish, in conjunction with other organizations, a national initiative which highlights hand hygiene and promotes vaccination to reduce the need for antibiotics;
b. to complete and publish the RICH study done by Dick Zoutman at Queens (this may include highlights published in Health Canada documents and/or Hospital Quarterly as well as encouraging coverage in the mass media;
c. to provide educational opportunities for health care professionals on disease prevention (in conjunction with other groups such as Deans of Medical Schools and NASI).
The key medium to long term priorities will be:
a. Encourage research into best practices for infection prevention and control in hospital, long term care and day care environments;
b. Expand and develop local and regional partnerships with other organizations including school boards and the College of Health Care Executives.
Membership:
The members will be representatives from the Canadian health care community with an interest in infection prevention, containment and control. Members will be appointed by CCAR. Working Group membership is expected to change over time. Initial Working Group members include:
John Conly
Erica Bontovics
Nora Boyd (Chair)
Sandra Callery
Cathy Egan
Judy Morrison
Susan Morrison
Pat Piaskowski
Liz VanHorne
Rick Walter
Meetings:
Meetings will generally be held via teleconference and are expected to be held several times per year. Meetings will called by the Chair and members will be provided at least one week prior notice.
Term:
It is expected that the Working Group will remain active until at least March 31, 2007.
OCTOBER 2007
UPCOMING EVENTS
AMMI CANADA - CACMID ANNUAL CONFERENCE
26TH INT'L CONGRESS OF CHEMOTHERAPY AND INFECTION
CHICA-CANADA 2008 NATIONAL EDUCATION CONFERENCE
NEW WEBSITE
CIPARS NEW WEBSITE PLUS 2005 ANNUAL REPORT AND 2006 PRELIMINARY NUMBERS
AUGUST 2007
NEW WEBSITE FOR NORTHERN ANTIBIOTIC RESISTANCE PARTNERS
JUNE 2007
INFECTION PREVENTION AND CONTROL BEST PRACTICES
MARCH 2007
Swedres 2005 - Swedish Antibiotic Utilisation and Resistance Report
BC AUDITOR GENERAL RELEASES REPORT ON INFECTION CONTROL
BUGS AND DRUGS POCKET REFERENCE NOW AVAILABLE
FEBRUARY 2007
CIPARS 2005 PRELIMINARY RESULTS
DECEMBER 2006
NEW SECTION:
STAPH INFECTIONS IN SPORT
FOR MORE INFORMATION CLICK HERE
NOVEMBER 2006
BACKGROUNDER CA-MRSA / STAPH INFECTIONS
FOR MORE INFORMATION CLICK HERE
OCTOBER 2006
CCAR ANNUAL REPORT
CCAR ANNUAL MEETING SUMMARY
SEPTEMBER 2006
New guidelines available to assist medical community
in fight against CA-MRSA